MorphoSys ( MOR ) AG  is reportedly facing a burgeoning safety concern surrounding pelabresib, an experimental myelofibrosis treatment. Myelofibrosis is a type of blood cancer characterized by the buildup of scar tissue, called “fibrosis,” in the bone marrow. Physicians participating in MorphoSys’ Phase 3 study have observed instances when patients treated with pelabresib swiftly transitioned from myelofibrosis to acute myeloid leukemia (AML), a more aggressive form...

12:35 PM EDT, 04/29/2024 (MT Newswires) -- Paramount (PARA) was up nearly 4% in recent trading Monday after Skydance Media raised its buyout offer by $3 billion in cash for Paramount to pay down debt, buy back stock and fund other activities, according to multiple media reports. The revised bid is also aimed at attracting Paramount investors who balked at...

ROME, April 29 (Reuters) - Italy and France on Monday signed a letter of intent to create a joint industrial hub for ground defence involving companies from both countries, an Italian defence ministry statement said, looking to boost the European defence industry. The announcement came after a meeting in the Mediterranean island of Corsica between defence ministers Guido Crosetto and...

Clever Leaves Holdings Inc ( CLVR ) shares are trading lower by 62% to $1.56 during Monday’s session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister its Securities to terminate and suspend its reporting obligations. The company notified Nasdaq of its intention and plans to file necessary forms with the SEC...